Annual report pursuant to Section 13 and 15(d)

Marketable Securities (Details Narrative)

v3.3.1.900
Marketable Securities (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Net loss $ (50,122,000) $ (99,000)
MusclePharm, Inc. [Member]    
Common Stock 260,000  
Net loss $ 1,686,000 $ 584,000